BrandEseence

Gene Editing Tools Market

Gene Editing Tools Market Size, Share & Trends Analysis Report

Gene Editing Tools Market Market Size Share Companies & Trends Analysis Report By Product (Transposon Systems, Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9), Viral Systems), By Application (Food & Brewing Development, Cell Line Engineering, Veterinary Medicine, Food Waste Management, Bioremediation, Biosensing Development), Based On Region And Segment Forecasts 2022 - 2028

Published
Report ID : BMRC 2084
Number of pages : 300
Published Date : Nov 2022
Category : Healthcare
Delivery Timeline : 48 hrs
Single User : $3250

Corporate User : $7999

Gene Editing Tools Market is valued at USD 412.9 Million in 2021 and expected to reach USD 1362.6 Million by 2028 with a CAGR of 18.6% over the forecast period. 

Global Gene Editing Tools Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- Increasing prevalence of cancer and other genetic disorders, rising technological advancements, and growing cases of chronic disease are some of the major factors driving the growth of the Global Gene Editing Tools Market. 

Scope of Global Gene Editing Tools Market Report- 

Gene-editing tools are technologies used to change or modify a specific part of an organism's DNA sequence. The most common & widely used type of this tool is the CRISPR-Cas system which belongs to a protein family called type II bacterial clustered regularly interspaced short palindromic repeats (CRISPR). This technique was first identified in bacteria but has now been applied to various applications including plants, animals, human cell lines, etc. The term """"gene editing"""" can therefore be defined as any process where single base pair changes are introduced into genetic sequences.  

The Covid-19 pandemic has shown a positive impact on the growth of the global gene editing tools market. Testing is a key component of the response to the Covid-19 pandemic in most regions. However, to comply with mass testing protocols, CRISPR-Cas9 products with their nucleotide-targeting capabilities make them ideal for detecting the presence of viral RNA. This has increased the demand for gene editing tools during the pandemic. 

The global gene editing tools market is segmented on the product, application, and region & country level. Based on product, the global gene editing tools market is segmented into transposon systems, zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), clustered regularly interspaced short palindromic repeats (CRISPR/Cas9), viral systems, and others. By application, the global gene editing tools market is segmented into food & brewing development, cell line engineering, veterinary medicine, food waste management, bioremediation, biosensing development, and others.  

The regions covered in the global gene editing tools market report are North America, Europe, Asia-Pacific, Latin America, and the rest of the World. Based on country level, the market of global gene editing tools is sub divided into U.S., Mexico, Canada, U.K., France, Germany, China, Italy, India, Japan, Southeast Asia, Middle East Asia (Saudi Arabia, UAE, Egypt) GCC, Africa, etc. 

Key Players of Global Gene Editing Tools Market Report- 

Some major key players for the global gene editing tools market report cover prominent players like ERS Genomics, Crispr Therapeutics, Merck KGaA, Editas Medicine, Takara Bio USA, New England Biolabs, Intellia Therapeutics, Inc., GenScript Biotech Corporation, Thermo Fisher Scientific Inc., and others.  

Report Analysis Details
Historical data 2018 - 2021
Forecast Period 2022 - 2028
Market Size in 2021: USD 412.9 Million 
Base year considered 2021
Forecast Period CAGR %:

18.6% 

Market Size Expected in 2028: USD 1362.6 Million 
Tables, Charts & Figures: 175
Pages 200
Gene Editing Key Players ERS Genomics, Crispr Therapeutics, Merck KGaA, Editas Medicine, Takara Bio USA, New England Biolabs, Intellia Therapeutics, Inc., GenScript Biotech Corporation, Thermo Fisher Scientific Inc., and others.  
Segments Covered By Product, By Application
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

 

News- 

Chinese Scientists Developed A New ‘Controllable and Reversible’ Gene-Editing Technique 

On August 17th, 2022; Chinese researchers developed a new gene-editing tool that is more efficient and safer because it does not permanently alter the genome. Scientists from the Chinese Academy of Sciences said the new device uses CRISPR (clustered regularly interspaced short palindromic repeat) technology - a natural defense mechanism that allows the detection and destruction of viruses that attack bacterial cells and has become one of the most commonly used genes - Editing techniques in recent years. 

Increasing Prevalence of Cancer and Other Genetic Disorders, Rising Number of Technological Advancements, and Growing Cases of Chronic Disease are Some of the Major Factors Driving the Market Growth  

One of the significant factors driving the growth of the gene editing tools market is the increasing prevalence of cancer and other genetic disorders such as sickle cell disease, heart disease, diabetes, Alzheimer's disease, obesity, and others, which are significant factors influencing the growth of the market. In the world, cancer is reported as the second leading cause of death. For instance; according to The World Health Organization; cancer is the leading cause of death worldwide, with about 10 million deaths in 2020. Thus, gene editing is given top priority for the management of rare genetic disorders, which is increasing the demand for gene editing, thus creating a favorable revenue opportunity for the market. The increasing prevalence and incidence of rare genetic disorders, mainly sickle cell disease (SKD), cancer, and Alzheimer's disease has led to high demand for genome editing and is a leading factor contributing significantly to the growing market. Gene editing tools, such as CRISPR, TALENs, and ZFNs, find precise applications in cancer treatment. Due to the high efficiency and precision of the CRISPR-Cas9 gene editing technique, it has emerged as a potential tool for cancer treatment. Among its various applications, CRISPR-Cas9 has high clinical potential to discover new target genes for cancer therapy. 

In addition, the rising number of technological advancements is also supplementing the growth of the gene editing tools market. Recent advances in CRISPR gene editing tools and their ease of use have generated considerable interest in the biomedical community. Clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing has high potential to address the therapeutic landscape of induced disorders, with the presence of major industry players such as Intellia, CRISPR Therapeutics, and Editas. CRISPR gene editing tools offer precise gene-targeted therapies for β-thalassemia and SKD. Among gene editing tools, there are potential applications for CRISPR in the market for gene editing tools in human therapeutics as well as veterinary treatments. For instance; as per the news published, on march 30th, 2021; Scientists launched a clinical trial of CRISPR gene correction therapy in patients with sickle cell disease. Therefore, many innovations in various (CRISPR)-based gene editing promote the growth of the gene editing tools market. 

Moreover, the growing cases of chronic disease are also fostering the gene editing tools market growth. For example; according to the Center for Disease Control and Prevention, on September 17th, 2020; 51.8% of US adults had at least one chronic condition, and 27.2% had multiple chronic conditions. However, the high cost associated with gene editing tools may hinder the market growth. Despite that, technological advancements in gene editing tools may create more opportunities for the further growth of the market. 

North America is Expected to capture a Major Share in the Global Gene Editing Tools Market 

Geographically, North America is expected to capture a major share in the global gene editing tools market within the forecast period due to the increasing cases of cancer, highly developed healthcare infrastructure, and high investments by large pharmaceutical and biotechnology companies in research activities in this region. Increasing cases of cancer are driving the growth of the market. For instance; according to National Cancer Institute, 1,806,590 new cases of cancer will be diagnosed in the United States and 606,520 people will die from the disease in 2020. In addition, the rising number of technological advancements is also supplementing the market growth in this region. For instance; as per the news published, on May 3rd, 2022; the TALED tool launched a new era of mitochondrial genome editing. TALEDs are DNA base editors capable of A-to-G base conversion on the mitochondrial genome. The discovery could be considered the final piece of the gene-editing technology puzzle. 

The Asia Pacific is the fastest-growing region in the global gene editing tools market due to the increasing prevalence of cancer, and growing investment in healthcare research and development activities in this region. For example; according to an article published on Down to earth; another study revealed that as many as 1,392,179 people were diagnosed with cancer in India in 2020. The researchers found that the five main sites of the disease were the breast, lungs, mouth, uterus, cervix, and tongue. 

Global Gene Editing Tools Market Segmentation:

By Product

  • Transposon Systems 
  • Zinc Finger Nucleases (ZFNs) 
  • Transcription Activator-Like Effector Nucleases (TALENs) 
  • Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
  • Viral Systems
  • Others 

By Application

  • Food & Brewing Development 
  • Cell Line Engineering
  • Veterinary Medicine
  • Food Waste Management
  • Bioremediation
  • Biosensing Development
  • Others 

Gene Editing Tools Market key Players:

  • ERS Genomics
  • Crispr Therapeutics
  • Merck KGaA
  • Editas Medicine
  • Takara Bio USA
  • New England Biolabs
  • Intellia Therapeutics, Inc.
  • GenScript Biotech Corporation
  • Thermo Fisher Scientific Inc.

Key Benefits of Global Gene Editing Tools Market Report– 

  • Global Gene Editing Tools Market report covers in-depth historical and forecast analysis 
  • Global Gene Editing Tools Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. 
  • Global Gene Editing Tools Market report helps to identify opportunities in marketplace.    
  • Global Gene Editing Tools Market report covers extensive analysis of emerging trends and competitive landscape. 
SUMMARY
VishalSawant
Vishal Sawant
Busines Development
vishal@brandessenceresearch.com
+91 8830 254 358

+44-1173181773

sales@brandessenceresearch.com

We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com

JOIN US

LONDON OFFICE

BrandEssence® Market Research and Consulting Pvt ltd.

Kemp House, 152 - 160 City Road, London EC1V 2NX

FOLLOW US

Twitter
Facebook
LinkedIn
Skype
YouTube

CONTACT US

1-888-853-7040 - U.S. (TOLL FREE)
+44-1173181773 - U.K. OFFICE
+91-7447409162 - INDIA OFFICE

© Copyright 2022-23 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®

PaymentModes